Around the Helix: Gene and Cell Therapy Company Updates - January 26, 2022
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.
The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in and out of the lab. GeneTherapyLive’s Around the Helix is your chance to catch up with the latest news in gene and cell therapies, including partnerships, pipeline updates, and more.
1. Kriya Licenses Next-Generation Gene Therapies for Geographic Atrophy
The Medical University of South Carolina (MUSC) Foundation for Research Development is developing next generation complement-targeted gene therapies. Kriya Therapeutics has entered into an
2. New Platform to Improve Accessibility of Cell and Gene Therapies
AmerisourceBergen and TrakCel have
3. IND Cleared for Solid Tumors TCR Therapy
Lyell Immunopharma is developing LYL132, an NY-ESO-1-targeted T-cell receptor therapy in collaboration with GlaxoSmithKline. The therapy is developed using Lyell’s novel epigenetic reprogramming Epi-R technology. The companies are set to initiate a phase 1/2 trial following the
4. T-Cell Therapy Gets Orphan Drug Designation for Pancreatic Cancer
The FDA has granted
5. CLN6 Batten Disease Gene Therapy Discontinued Due to Durability Issues
Amicus Therapeutics has made the decision to discontinue
6. Stem Cell Gene Therapy Efficacious in Metachromatic Leukodystrophy
Orchard Therapeutics’ gene therapy atidarsageneautotemcel (arsa-cel;,Libmeldy)
7. Tevogen Bio to Study T-Cell Technology in EBV and MS
Following the
8. Adaptimmune to Evaluate TCR-T Therapy in Advanced Esophageal or EGJ Cancers
The company’s cell therapy
9. Lysogene Terminates Agreement With Sarepta for Mucopolysaccharidosis Type 3A Gene Therapy
Lysogene will
10. Idecabtagene Vicleucel Approved in Japan for Relapsed/Refractory Multiple Myeloma
The approval of Abecma (Bristol Myers Squibb; bluebird bio) marks the
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Around the Helix: Cell and Gene Therapy Company Updates – September 17, 2025
September 17th 2025
- ImmunoLogic, Episode 6: "The Future of Personalized Cancer Vaccines”
September 15th 2025
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025